Literature DB >> 7512479

Influence of antihypertensive drugs on exercise capacity.

R Fagard1, J Staessen, L Thijs, A Amery.   

Abstract

Both single dose and short term diuretic treatment adversely affect maximal exercise capacity and the duration of prolonged submaximal exercise. However, insufficient data are available to establish the effect of long term diuretic treatment on exercise capacity. beta-Blockade reduces maximal aerobic power by approximately 7%. In addition, the capacity for prolonged submaximal exercise appears to be markedly impaired in normotensive and hypertensive patients, particularly when nonselective beta-blockers are prescribed. Fewer data are available for other drugs, but, whatever the mechanism of vasodilation, drugs that reduce systemic vascular resistance do not seem to have any effect on exercise capacity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7512479     DOI: 10.2165/00003495-199300462-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  34 in total

1.  Beta-blockers: once or three times a day?

Authors:  T Reybrouck; A Amery; R Fagard; P Jousten; P Lijnen; E Meulepas
Journal:  Br Med J       Date:  1978-05-27

2.  Glucagon and plasma catecholamines during beta-receptor blockade in exercising man.

Authors:  H Galbo; J J Holst; N J Christensen; J Hilsted
Journal:  J Appl Physiol       Date:  1976-06       Impact factor: 3.531

3.  Effect of oxprenolol on stage-fright in musicians.

Authors:  I M James; D N Griffith; R M Pearson; P Newbury
Journal:  Lancet       Date:  1977-11-05       Impact factor: 79.321

4.  Effect of beta-adrenoceptor blockade on exercise performance and metabolism.

Authors:  P Lundborg; H Aström; C Bengtsson; E Fellenius; H von Schenck; L Svensson; U Smith
Journal:  Clin Sci (Lond)       Date:  1981-09       Impact factor: 6.124

5.  Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.

Authors:  D P Myburgh; N F Gordon
Journal:  Am J Cardiol       Date:  1987-11-01       Impact factor: 2.778

6.  Exercise tolerance with nebivolol and atenolol.

Authors:  L M Van Bortel; M A van Baak
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

7.  Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.

Authors:  P E Pool; S C Seagren; A F Salel
Journal:  Am J Cardiol       Date:  1985-12-06       Impact factor: 2.778

8.  Diltiazem versus propranolol in essential hypertension: responses of rest and exercise blood pressure and effects on exercise capacity.

Authors:  J Szlachcic; A T Hirsch; J F Tubau; C Vollmer; S Henderson; B M Massie
Journal:  Am J Cardiol       Date:  1987-02-15       Impact factor: 2.778

9.  Effects of beta-adrenergic blockade on O2 uptake during submaximal and maximal exercise.

Authors:  P A Tesch; P Kaiser
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-04

10.  Effects of beta-adrenergic blockade on ventilation and gas exchange during exercise in humans.

Authors:  E S Petersen; B J Whipp; J A Davis; D J Huntsman; H V Brown; K Wasserman
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-05
View more
  3 in total

Review 1.  Exercise metabolism and beta-blocker therapy. An update.

Authors:  A Head
Journal:  Sports Med       Date:  1999-02       Impact factor: 11.136

Review 2.  The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis.

Authors:  Amy B Cadwallader; Xavier de la Torre; Alessandra Tieri; Francesco Botrè
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

3.  Patients' responses to risk information about the benefits of treating hypertension.

Authors:  D Misselbrook; D Armstrong
Journal:  Br J Gen Pract       Date:  2001-04       Impact factor: 5.386

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.